Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,903 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sensitivity and specificity of Cobas TaqMan MTB real-time polymerase chain reaction for culture-proven Mycobacterium tuberculosis: meta-analysis of 26999 specimens from 17 Studies.
Horita N, Yamamoto M, Sato T, Tsukahara T, Nagakura H, Tashiro K, Shibata Y, Watanabe H, Nagai K, Nakashima K, Ushio R, Ikeda M, Sakamaki K, Yoshiyama T, Kaneko T. Horita N, et al. Among authors: nakashima k. Sci Rep. 2015 Dec 9;5:18113. doi: 10.1038/srep18113. Sci Rep. 2015. PMID: 26648113 Free PMC article.
Progression-Free Survival, Response Rate, and Disease Control Rate as Predictors of Overall Survival in Phase III Randomized Controlled Trials Evaluating the First-Line Chemotherapy for Advanced, Locally Advanced, and Recurrent Non-Small Cell Lung Carcinoma.
Nakashima K, Horita N, Nagai K, Manabe S, Murakami S, Ota E, Kaneko T. Nakashima K, et al. J Thorac Oncol. 2016 Sep;11(9):1574-85. doi: 10.1016/j.jtho.2016.04.025. Epub 2016 May 10. J Thorac Oncol. 2016. PMID: 27178983 Free article. Clinical Trial.
Diagnostic test accuracy of anti-glycopeptidolipid-core IgA antibodies for Mycobacterium avium complex pulmonary disease: systematic review and meta-analysis.
Shibata Y, Horita N, Yamamoto M, Tsukahara T, Nagakura H, Tashiro K, Watanabe H, Nagai K, Nakashima K, Ushio R, Ikeda M, Narita A, Kanai A, Sato T, Kaneko T. Shibata Y, et al. Among authors: nakashima k. Sci Rep. 2016 Jul 4;6:29325. doi: 10.1038/srep29325. Sci Rep. 2016. PMID: 27373718 Free PMC article. Review.
Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD).
Horita N, Goto A, Shibata Y, Ota E, Nakashima K, Nagai K, Kaneko T. Horita N, et al. Among authors: nakashima k. Cochrane Database Syst Rev. 2017 Feb 10;2(2):CD012066. doi: 10.1002/14651858.CD012066.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2023 Jun 5;6:CD012066. doi: 10.1002/14651858.CD012066.pub3 PMID: 28185242 Free PMC article. Updated. Review.
HbA1c level cannot predict the treatment outcome of smear-positive non-multi-drug-resistant HIV-negative pulmonary tuberculosis inpatients.
Tashiro K, Horita N, Nagai K, Ikeda M, Shinkai M, Yamamoto M, Sato T, Hara Y, Nagakura H, Shibata Y, Watanabe H, Nakashima K, Ushio R, Nagashima A, Narita A, Kobayashi N, Kudo M, Kaneko T. Tashiro K, et al. Among authors: nakashima k. Sci Rep. 2017 Apr 13;7:46488. doi: 10.1038/srep46488. Sci Rep. 2017. PMID: 28406247 Free PMC article. Clinical Trial.
Factors for Predicting Outcomes among Non-HIV Patients with Pulmonary Tuberculosis.
Tsukahara T, Horita N, Tashiro K, Nagai K, Shinkai M, Yamamoto M, Sato T, Hara Y, Nagakura H, Shibata Y, Watanabe H, Nakashima K, Ushio R, Nagashima A, Ikeda M, Narita A, Sasaki K, Kobayashi N, Kudo M, Kaneko T. Tsukahara T, et al. Among authors: nakashima k. Intern Med. 2017 Dec 15;56(24):3277-3282. doi: 10.2169/internalmedicine.9120-17. Epub 2017 Oct 11. Intern Med. 2017. PMID: 29021438 Free PMC article.
2,903 results